RFK Jr. considering ‘framework’ for Medicaid, Medicare coverage of GLP-1s

Congress should allow Medicare to offer coverage for anti-obesity medications

Thirteen states cover GLP-1 drugs through their Medicaid programs, and others are considering following suit (Mario Tama/Getty Images).President Donald Trump and Health Secretary Robert F. Kennedy Jr. have pledged to “make America healthy again.” If Congress wants to actually take a step in that direction, it should pass legislation that would allow Medicare to finally offer coverage for anti-obesity medications. Right now, our Medicare system i…

RFK Jr. considering ‘framework’ for Medicaid, Medicare coverage of GLP-1s

Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. said he is considering a “regulatory framework” for Medicare and Medicaid to cover GLP-1 medications to treat obesity. Kennedy said in a CBS News interview that aired Wednesday the high cost of the medication is the biggest hurdle to coverage, but he said he’s considering…

Pharmaceutical Market Trend Insight, Experts Talk GLP-1 Competition and More

Current observations and foresight into the world of biosimilars, GLP-1s, PBM and payer trends, according to Jeff Casberg, MS, RPh, senior vice president of clinical pharmacy services at IPD Analytics, and Doug Long, MBA, vice president of industry relations at IQVIA.